CANbridge and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics Read more
Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration Read more
Mesoblast Expands Partnership With JCR for Treatment of Wound Healing in Epidermolysis Bullosa Read more
Purdue Pharma Enters into Exclusive Option Agreement to Acquire SpineThera and Its Non-Opioid Product Read more
Orgenesis Announces Collaboration with Hemogenyx to Develop Blood Stem Cell Replacement Product Read more